Evaluation of Anti-aging Agents Using the D-Galactose-Induced Accelerated Aging Model

Serdar Bora Bayraktaroğlu1,2, Raife Dilek Turan1, Neslihan Pakize Taşlı1

  • 1Yeditepe Universitesi, Istanbul, Turkey.

Insights

Novel anti-aging agents like exosomes and boron compounds show promise in reversing aging. Studies using accelerated aging models in vitro and in vivo reveal their potential to combat age-related decline.

Area of Science:

  • Gerontology and Regenerative Medicine
  • Biotechnology and Nanomedicine

Background:

  • The global population is aging, increasing the need for effective anti-aging strategies.
  • Understanding aging mechanisms is crucial for developing interventions to improve healthspan.

Purpose of the Study:

  • To investigate the efficacy of novel anti-aging agents, specifically exosomes and boron compounds.
  • To evaluate these agents in a D-galactose-induced accelerated aging model.

Main Methods:

  • Utilized both in vitro (skin organoid models) and in vivo (rat models) experimental systems.
  • Analyzed cellular, molecular, and histological changes associated with aging and treatment.

Main Results:

  • Exosomes and boron compounds demonstrated potential in mitigating age-associated pathologies.
  • Observed reversal of specific aging markers at cellular and molecular levels.

Conclusions:

  • Novel agents like exosomes and boron compounds hold significant therapeutic potential for aging.
  • Further research into these agents could lead to effective anti-aging therapies.